Most common relevant bleeding events among patients prescribed FXA inhibitors (N = 890).

<p>FXA, Factor XA; ICD-10, <i>International Classification Of Diseases, 10th revision</i>. A total of 890/9470 (9.4%) patients on FXA inhibitors experienced relevant bleeding events. only records comprising ≥0.5% of the total Cohort (N = 9470) are shown. All data are shown in <a...

Full description

Saved in:

Bibliographic Details
Main Author:	Sofia D’Abrantes (21273231) (author)
Other Authors:	Christoph Male (62135) (author), Nick Brown (1228626) (author), Mikael Bjursell (274867) (author), Philip Ambery (3355787) (author), Anders Berggren (3758089) (author), Ulrika Mattsson (21273234) (author)
Published:	2025
Subjects:	Medicine Pharmacology Biotechnology Developmental Biology Chemical Sciences not elsewhere classified world study aimed reversal agent use possible unmet need data mart database identify patients aged anticoagulant prescribing trends trinetx global network div >< p assess potential populations 18 years old among patients prescribed similar trends pediatric patients patients prescribed weight heparins relevant bleeding optum ’ factor xa deidentified clinformatics clinical trials bleeding events associated bleeds anticoagulants prescribed 6470 ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Most common relevant bleeding events among patients prescribed FXA inhibitors (N = 890).

Similar Items